The prevalence of weight loss during (chemo)radiotherapy treatment for lung cancer and associated patient- and treatment-related factors
Nicole Kiss, Elisabeth Isenring, Karla Gough, Meinir Krishnasamy
Clinical Nutrition | CHURCHILL LIVINGSTONE | Published : 2014
BACKGROUND & AIMS: Thoracic radiotherapy is associated with toxicities that can adversely impact nutritional intake. This study aimed to investigate the prevalence and predictors of ≥5% weight loss and commencement of enteral nutrition in lung cancer patients receiving radiotherapy. METHODS: A retrospective study of 96 patients treated with high dose palliative or radical radiotherapy for a primary diagnosis of small cell or non-small cell lung cancer. Weight loss was calculated between the start and up to 90 days from radiotherapy commencement. Associations between ≥5% weight loss and enteral feeding, and demographic and clinical factors (age, gender, nutritional status, total dose of radio..View full abstract
Related Projects (10)
RANDOMISED PHASE III TRIAL OF ADJUVANT RADIOTHERAPY VERSUS OBSERVATION FOLLOWING BREAST CONSERVING SURGERY AND ENDOCRINE THERAPY IN PATIENTS WITH MOLECULARLY CHARACTERISED LOW-RISK LUMINAL A EARLY BREAST CANCER
Radiotherapy after surgery for early breast cancer decreases recurrence but its benefit varies. Thus, it is important to identify low-risk p..
The study was supported by a PhD scholarship from the Victorian Cancer Agency, Melbourne, Australia. The sponsors had no involvement in the study.